BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 27101556)

  • 1. A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression.
    Mazidi M; Shemshian M; Mousavi SH; Norouzy A; Kermani T; Moghiman T; Sadeghi A; Mokhber N; Ghayour-Mobarhan M; Ferns GA
    J Complement Integr Med; 2016 Jun; 13(2):195-9. PubMed ID: 27101556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression.
    Tabeshpour J; Sobhani F; Sadjadi SA; Hosseinzadeh H; Mohajeri SA; Rajabi O; Taherzadeh Z; Eslami S
    Phytomedicine; 2017 Dec; 36():145-152. PubMed ID: 29157808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Saffron on Cognition, Anxiety, and Depression in Patients Undergoing Coronary Artery Bypass Grafting: A Randomized Double-Blind Placebo-Controlled Trial.
    Moazen-Zadeh E; Abbasi SH; Safi-Aghdam H; Shahmansouri N; Arjmandi-Beglar A; Hajhosseinn Talasaz A; Salehiomran A; Forghani S; Akhondzadeh S
    J Altern Complement Med; 2018 Apr; 24(4):361-368. PubMed ID: 29185780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. affron
    Kell G; Rao A; Beccaria G; Clayton P; Inarejos-García AM; Prodanov M
    Complement Ther Med; 2017 Aug; 33():58-64. PubMed ID: 28735826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial.
    Agha-Hosseini M; Kashani L; Aleyaseen A; Ghoreishi A; Rahmanpour H; Zarrinara AR; Akhondzadeh S
    BJOG; 2008 Mar; 115(4):515-9. PubMed ID: 18271889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo-controlled trial.
    Akhondzadeh S; Tahmacebi-Pour N; Noorbala AA; Amini H; Fallah-Pour H; Jamshidi AH; Khani M
    Phytother Res; 2005 Feb; 19(2):148-51. PubMed ID: 15852492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of saffron (Crocus sativus L.) on mental health parameters and C-reactive protein: A meta-analysis of randomized clinical trials.
    Ghaderi A; Asbaghi O; Reiner Ž; Kolahdooz F; Amirani E; Mirzaei H; Banafshe HR; Maleki Dana P; Asemi Z
    Complement Ther Med; 2020 Jan; 48():102250. PubMed ID: 31987241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. affron
    Lopresti AL; Drummond PD; Inarejos-García AM; Prodanov M
    J Affect Disord; 2018 May; 232():349-357. PubMed ID: 29510352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial [ISRCTN45683816].
    Akhondzadeh S; Fallah-Pour H; Afkham K; Jamshidi AH; Khalighi-Cigaroudi F
    BMC Complement Altern Med; 2004 Sep; 4():12. PubMed ID: 15341662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Crocus sativus (saffron) in treatment of major depressive disorder associated with post-menopausal hot flashes: a double-blind, randomized, placebo-controlled trial.
    Kashani L; Esalatmanesh S; Eftekhari F; Salimi S; Foroughifar T; Etesam F; Safiaghdam H; Moazen-Zadeh E; Akhondzadeh S
    Arch Gynecol Obstet; 2018 Mar; 297(3):717-724. PubMed ID: 29332222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
    Talaei A; Hassanpour Moghadam M; Sajadi Tabassi SA; Mohajeri SA
    J Affect Disord; 2015 Mar; 174():51-6. PubMed ID: 25484177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo controlled randomized clinical trial of Crocus sativus L. (saffron) on depression and food craving among overweight women with mild to moderate depression.
    Akhondzadeh S; Mostafavi SA; Keshavarz SA; Mohammadi MR; Hosseini S; Eshraghian MR
    J Clin Pharm Ther; 2020 Feb; 45(1):134-143. PubMed ID: 31602695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial.
    Akhondzadeh S; Sabet MS; Harirchian MH; Togha M; Cheraghmakani H; Razeghi S; Hejazi SSh; Yousefi MH; Alimardani R; Jamshidi A; Zare F; Moradi A
    J Clin Pharm Ther; 2010 Oct; 35(5):581-8. PubMed ID: 20831681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of saffron (Crocus sativus L.) on lipid profile, glycemic indices and antioxidant status among overweight/obese prediabetic individuals: A double-blinded, randomized controlled trial.
    Karimi-Nazari E; Nadjarzadeh A; Masoumi R; Marzban A; Mohajeri SA; Ramezani-Jolfaie N; Salehi-Abargouei A
    Clin Nutr ESPEN; 2019 Dec; 34():130-136. PubMed ID: 31677703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial.
    Noorbala AA; Akhondzadeh S; Tahmacebi-Pour N; Jamshidi AH
    J Ethnopharmacol; 2005 Feb; 97(2):281-4. PubMed ID: 15707766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial.
    Moshiri E; Basti AA; Noorbala AA; Jamshidi AH; Hesameddin Abbasi S; Akhondzadeh S
    Phytomedicine; 2006 Nov; 13(9-10):607-11. PubMed ID: 16979327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crocus sativus L. versus Citalopram in the Treatment of Major Depressive Disorder with Anxious Distress: A Double-Blind, Controlled Clinical Trial.
    Ghajar A; Neishabouri SM; Velayati N; Jahangard L; Matinnia N; Haghighi M; Ghaleiha A; Afarideh M; Salimi S; Meysamie A; Akhondzadeh S
    Pharmacopsychiatry; 2017 Jul; 50(4):152-160. PubMed ID: 27701683
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of alcoholic extract of saffron (Crocus satious L.) on mild to moderate comorbid depression-anxiety, sleep quality, and life satisfaction in type 2 diabetes mellitus: A double-blind, randomized and placebo-controlled clinical trial.
    Milajerdi A; Jazayeri S; Shirzadi E; Hashemzadeh N; Azizgol A; Djazayery A; Esmaillzadeh A; Akhondzadeh S
    Complement Ther Med; 2018 Dec; 41():196-202. PubMed ID: 30477839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action.
    Lopresti AL; Drummond PD
    Hum Psychopharmacol; 2014 Nov; 29(6):517-27. PubMed ID: 25384672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Saffron versus Fluoxetine in Treatment of Mild to Moderate Postpartum Depression: A Double-Blind, Randomized Clinical Trial.
    Kashani L; Eslatmanesh S; Saedi N; Niroomand N; Ebrahimi M; Hosseinian M; Foroughifar T; Salimi S; Akhondzadeh S
    Pharmacopsychiatry; 2017 Mar; 50(2):64-68. PubMed ID: 27595298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.